Use of transdermal estrogen in the management of advanced prostate cancer

Urol Oncol. 2013 Feb;31(2):279. doi: 10.1016/j.urolonc.2012.08.016.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Quality of Life*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal